PedAM
Pediatric Disease Annotations & Medicines
| Disease | myocardial infarction |
| Symptom | |diabetes |
| Sentences | 128 |
| PubMedID- 20517158 | Conclusion: in acute st-segment elevation myocardial infarction patients without earlier known diabetes submitted to mechanical revascularization, the poorer in-hospital glucose control was associated with higher mortality; peak glycemia greater than 180 mg/dl was associated with the highest mortality, whereas patients with peak glycemia comprised between 140 and 180 mg/dl exhibited intermediate mortality rates. |
| PubMedID- 22462016 | Cardioprotective effect of liraglutide in comparison to metformin was showed in induced myocardial infarction in animals with diabetes, when similar metabolic control was achieved. |
| PubMedID- 20640879 | In men, serum cholesterol level and high-density lipoprotein level, diabetes mellitus and history of myocardial infarction were key risk factors for chd. |
| PubMedID- 24422205 | Age+previous and current smoking, waist circumference, systolic blood pressure, triglycerides, ldl cholesterol, diabetes, family history of myocardial infarction, total cholesterol and use of statins. |
| PubMedID- 25297571 | Aims/hypothesis: diabetes increases the risk of acute myocardial infarction (ami) and effective means for primary prevention are warranted. |
| PubMedID- 22403651 | Adjusted for age, body mass index, educational level, hypertension, hypercholesterolemia, diabetes, history of myocardial infarction and stroke. |
| PubMedID- 22963483 | Aims: following myocardial infarction (mi), individuals with diabetes have a two-fold increase in the risk of heart failure, due in part to excessive loss of cardiac microvasculature. |
| PubMedID- 26301192 | diabetes patients usually die of stroke, myocardial infarction, etc., and complications such as amputation of feet, blindness, renal failure, etc., seriously dampens the patients' quality of life and add economic burdens due to treatments . |
| PubMedID- 23286208 | Furthermore, short- and long-term survival following a myocardial infarction is lower in patients with type 2 diabetes mellitus compared to those without. |
| PubMedID- 22264268 | This relationship held true even after adjusting for age, gender, diabetes, hypertension, history of myocardial infarction or stroke, smoking status, and region of the country. |
| PubMedID- 25887378 | An informed shared decision making programme on the prevention of myocardial infarction for patients with type 2 diabetes in primary care: protocol of a cluster randomised, controlled trial. |
| PubMedID- 24254885 | However, they do not constitute sufficient evidence to indicate the routine use of chelation therapy for all post-myocardial infarction patients with diabetes mellitus. |
| PubMedID- 22709128 | In addition to matched variables, the following additional covariates were candidates for adjusted analyses based on clinical significance: diabetes, history of myocardial infarction, history of atrial fibrillation, history of chronic obstructive pulmonary disease, history of chronic liver disease, and systolic blood pressure, heart rate and creatinine clearance preceding readmission for cases or control time period for controls. |
| PubMedID- 22436146 | Importantly, the study population only included persons at risk for myocardial infarction (persons with hypertension, diabetes mellitus and/or dyslipidemia) and "healthy user" bias possibly occurred in selecting controls . |
| PubMedID- 22783203 | In these analyses, we regarded the following data as covariates for multivariate analysis: age category (70–74, 75–79, 80–84 years); sex; bmi (continuous variable); hypertension, hypercholesterolemia, diabetes mellitus, history of stroke, myocardial infarction, or angina pectoris, liver diseases, renal diseases (presence or absence); cognitive function (mini-mental state examination score of <24 or ≥24); depressive symptoms (geriatric depression scale scores of <11 or ≥11); smoking (never, former, and current smoker); use of alcohol (never, former, and currently drinking); use of tranquilizer (yes or no); physical functioning status (mos scores continuous variables); leisure-time physical activity (level 1: no sports, no brisk walking, no walking; level 2: no sports, no brisk walking; low amount of walking; level 3: no sports, no brisk walking, high amount of walking; level 4: no sports, low amount of brisk walking, any amount of walking; level 5: no sports, high amount of brisk walking, any amount of walking; level 6: any amount of sports, any amounts of brisk walking, any amount of walking). |
| PubMedID- 20083247 | Impact of diabetes on survival in patients with st-segment elevation myocardial infarction treated by primary angioplasty: insights from the polish stemi registry. |
| PubMedID- 22611064 | A dysfunction of autonomic nervous system has been associated with increased mortality after myocardial infarction (13,14) in patients with diabetes (15,16) and in the general population (17). |
| PubMedID- 24843443 | Furthermore, anemia is accompanied by cardiovascular events9–12, mortality13 and mortality after acute myocardial infarction16 in patients with diabetes mellitus. |
| PubMedID- 26076939 | Improving 30-day case fatality after incident myocardial infarction in people with diabetes between 1998 and 2010. |
| PubMedID- PMC3952941 | Exclusion criteria were clinical coronary artery disease, chronic renal disease, diabetes mellitus, hypertension, history of myocardial infarction, angina pectoris or cerebrovascular disease, dyslipidemia, metabolic syndrome or active infection. |
| PubMedID- 20211319 | In conclusion, an eesbpr was associated with improved survival and a lower rate of death or myocardial infarction in patients with diabetes mellitus and known or suspected cad. |
| PubMedID- 20233394 | myocardial infarction for people with diabetes, and vice versa) is controlled for in the logistic regression model (tables 5 and 6). |
| PubMedID- 20157205 | It was found that 178 (52.4%) patients with type 2 diabetes had law risk of development of myocardial infarction, 89 (26.2%) patients - moderate and 73 patients (21.4%) - the high risk of myocardial infarction. |
| PubMedID- 25918532 | His family history was positive for cataract and glaucoma (father), diabetes (brother of mother), and myocardial infarction (mother). |
| PubMedID- 23225175 | The second trial, the cardiovascular inflammation reduction trial (cirt) has been funded by the national heart, lung, and blood institute (nhlbi) and will evaluate whether low dose methotrexate (target dose 20 mg/week) as compared to placebo will reduce major vascular events among a group of post-myocardial infarction patients with either diabetes or metabolic syndrome, groups known to have high risk on the basis of a persistent pro-inflammatory response. |
| PubMedID- 20594348 | Data were acquired from human plasma obtained from a) an individual with congestive heart failure, diabetes, and a history of myocardial infarction (4.5% native form), and b) a healthy individual (66% native form). |
| PubMedID- 24229770 | Although pioglitazone significantly prevented the progression of coronary atherosclerosis and reduced the recurrence of myocardial infarction in patients with type 2 diabetes mellitus (dm), it remains unclear whether pioglitazone could attenuate coronary artery inflammation. |
| PubMedID- 24386093 | Independent determinants of cardiovascular events (myocardial infarction, stroke, death) in patients with pad and diabetes mellitus. |
| PubMedID- 23403268 | In multivariate cox analyses adjusting for age, sex, race, diabetes mellitus, history of heart failure, myocardial infarction, ischemic heart disease, stroke, smoking, serum high-density lipoprotein cholesterol, creatinine, glucose, and urine albumin/creatinine ratio as standard risk factors, and for incident myocardial infarction, in-treatment use of digoxin, systolic and diastolic pressure, heart rate, qrs duration, cornell voltage-duration product, and sokolow-lyon voltage left ventricular hypertrophy treated as time-varying covariates, new-onset af remained associated with a >3-fold increased risk of scd (hazard ratio, 3.13; 95% confidence interval, 1.87-5.24; p<0.001). |
| PubMedID- 24399329 | Risk of ischemic stroke after an acute myocardial infarction in patients with diabetes mellitus. |
| PubMedID- 26386939 | This study evaluated the association between sulfonylurea use and infarct size in diabetes patients with st-elevation myocardial infarction (stemi). |
| PubMedID- 21417718 | Patients with diabetes show dysfunction of cms independent of myocardial infarction, indicating that diabetes directly affects cms. |
| PubMedID- 22847458 | An increasing number of elderly people and diabetes patients with myocardial infarction go unrecognized because of painless ischemia and regression of major q-waves over time. |
| PubMedID- 20843380 | We therefore set out to investigate the association between individual oral glucose-lowering drugs and cardiovascular outcomes following myocardial infarction in patients with diabetes mellitus not treated with emergent percutaneous coronary intervention. |
| PubMedID- 26331054 | It is only now being appreciated that aki survivors have similar long-term outcomes as patients with diabetes and survivors of a st-elevation myocardial infarction . |
| PubMedID- 23108517 | Baseline characteristics, such as age, gender, diabetes mellitus, history of previous myocardial infarction, killip class on admission and ecg pattern (including information regarding any bundle branch blocks – old, new or of unknown origin) were analysed. |
| PubMedID- 22377967 | Risk of ventricular arrhythmias after myocardial infarction with diabetes associated with sympathetic neural remodeling in rabbits. |
| PubMedID- 20478050 | More data are required not only for efficacy, but also to address the long-term safety of rosiglitazone in these patients, particularly in light of the recent report that rosiglitazone is associated with a significant increase in the risk of myocardial infarction in patients with type 2 diabetes mellitus . |
| PubMedID- 25300610 | The data observed were: age, sex, diabetes-related complications (annual rates of acute myocardial infarction, major amputations and avoidable hospitalisations), diabetes-related pathologies (prevalence of ischaemic heart disease, renal failure, stroke, heart failure, peripheral neuropathy, foot ulcers and diabetic retinopathy) and other unrelated pathologies (44 diseases). |
| PubMedID- 22279115 | Although the 7% prevalence of diabetes among patients with myocardial infarction is substantially lower than in other western countries,2 it is only slightly lower than reported in the second danish trial on acute myocardial infarction (danami-2) (11%).28 also, because the comparisons were made within a population of patients with myocardial infarction, underascertainment of comorbidities is unlikely to influence substantially the relative mortality estimates associated with comorbidity categories. |
| PubMedID- 21193625 | In addition, ace inhibitors have been shown to reduce major cvd outcomes (i.e., myocardial infarction, stroke, death) in patients with diabetes (207), thus further supporting the use of these agents in patients with microalbuminuria, a cvd risk factor. |
| PubMedID- 24934236 | Reduced levels of circulating endothelial progenitor cells in acute myocardial infarction patients with diabetes or pre-diabetes: accompanying the glycemic continuum. |
| PubMedID- 20965878 | diabetes mellitus in patients with myocardial infarction complicated by heart failure: a 'low ejection fraction' equivalent. |
| PubMedID- 25356815 | Exclusion criteria were age less than 35 years, type 1 diabetes mellitus, ecg evidence of q-wave myocardial infarction, ischemic st-segment or t-wave changes, or complete left-bundle branch block, a clinical history of cv disease, cerebrovascular disease, or malignancy, and an estimated modification of diet in renal disease gfr less than 60 ml/min/1.73 m2. |
| PubMedID- 23148342 | Sex, age, education, obesity, diabetes and history of myocardial infarction or hf were included as concomitants. |
| PubMedID- 25147705 | In a multicenter, randomized, double- blind, and prospective trial, atorvastatin had no statistically significant effect on the composite primary end point of cardiovascular death, nonfatal myocardial infarction, and stroke in patients with diabetes receiving hemodialysis. |
| PubMedID- 21576196 | An increased incidence of myocardial infarction with rosiglitazone in patients with type 2 diabetes mellitus (t2dm) has been reported. |
| PubMedID- 25879728 | Moreover, diabetes with prior myocardial infarction had much higher cardiovascular mortality (45%) than non diabetes with prior myocardial infarction (mi) (18.8%) 2. |
| PubMedID- 22567531 | Compared with patients with e′ ≥ 5.8 cm/s, those with e′ < 5.8 cm/s were more likely to be older, to have diabetes and history of myocardial infarction, to be prescribed angiotensin converting enzyme inhibitors/angiotensin receptor blockers, and to undergo coronary revascularization after the index cardiac catheterization and were less likely to be prescribed calcium blockers. |
| PubMedID- 26341185 | Comparison of changes in global longitudinal peak systolic strain after st-segment elevation myocardial infarction in patients with versus without diabetes mellitus. |